Clinical Trials Browser

Terminated × Immunoglobulin Light-chain Amyloidosis × Filgrastim × Clear all

NCT00052884 2023-06-18

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

NCT02489500 2018-09-10

VelRand

Phase 3 Terminated

3 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis

NCT00681044 2017-04-28

HD Melphalan and SCT in Patients With IGDD or LCDD

Phase 2 Terminated

5 enrolled 7 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

NCT00075608 2017-01-27

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Phase 2 Terminated

12 enrolled 6 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell